日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study

一项研究者发起的 II 期研究的最终报告:伊布替尼治疗伴或不伴 TP53 异常的慢性淋巴细胞白血病 (CLL) 十年的疗效

Itsara, Andy; Rogness, Victoria M; Samples, Laura; Yuan, Constance M; Wang, Hao-Wei; Ahn, Inhye E; Farooqui, Mohammed Z H; Tian, Xin; Sun, Clare; Tomasulo, Emily; Soto, Susan; Superata, Jeanine; Bezkorovaynaya, Larisa; Hughes, Thomas E; Nierman, Pia; Wiestner, Adrian

Central nervous system involvement in CLL: an international retrospective study by ERIC, the European Research Initiative on CLL

慢性淋巴细胞白血病中枢神经系统受累:欧洲慢性淋巴细胞白血病研究倡议(ERIC)的一项国际回顾性研究

Chatzikonstantinou, Thomas; Mikhaleva, Mariia; Brieghel, Christian; Papangelou, Christina; Minga, Eva; Arrais-Rodrigues, Celso; Besikli-Dimou, Sotiria; Cerutti, Amalia; Doubek, Michael; Enggaard, Lisbeth; Espinet, Blanca; Ferrer-Lores, Blanca; Garcia Vela, Jose Antonio; Gentile, Massimo; Vázquez, Eva Gimeno; Gutwein, Odit; Herishanu, Yair; Jablonowska-Babij, Paula; Jaksic, Ozren; Josefsson, Par; Kalicińska, Elzbieta; Kislova, Maria; Lista, Enrico; Kotsianidis, Ioannis; Marquet, Juan; Martino, Enrica Antonia; McAuley, Ciaran; Mela Osorio, Maria José; Moia, Riccardo; Mosquera, Claudia; Nikitin, Eugene; Pavlovsky, Miguel Arturo; Pfister, Verena; Savaş, Emine Merve; Scarfò, Lydia; Sever, Matjaz; Shvidel, Lev; Simkovic, Martin; Stavroyianni, Niki; Talimtzi, Persefoni; Tranidou, Antigoni; Visentin, Andrea; Vrachiolias, Georgios; Wasik-Szczepanek, Ewa; Wróbel, Tomasz; Yağcı, Münci; Cellini, Alessandro; Chatzidimitriou, Anastasia; Gaidano, Gianluca; Anderson, Mary Ann; Davids, Matthew S; Brown, Jennifer R; Niemann, Carsten U; Stamatopoulos, Kostas; Ghia, Paolo; Ahn, Inhye E; Koren-Michowitz, Maya

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断后进展的经典霍奇金淋巴瘤患者

Merryman, Reid W; Kline, Justin; Redd, Robert A; Olszewski, Harrison; Welsh, Emma; Pfaff, Kathleen; Lee, Hannah; McDonough, Mikaela; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; Odejide, Oreofe O; Parry, Erin Michelle; Ryan, Christine E; Shipp, Margaret A; Armand, Philippe; Rodig, Scott; Abramson, Jeremy S; LaCasce, Ann S

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells

通过靶向共价沉积在淋巴瘤细胞上的补体C3片段来增强CD20单克隆抗体疗法的疗效

Baskar, Sivasubramanian; Peng, Haiyong; Gaglione, Erika M; Carstens, Elizabeth J; Lindorfer, Margaret A; Ahn, Inhye E; Herman, Sarah E M; Skarzynski, Martin; Chang, Jing; Keyvanfar, Keyvan; Butera, Vicent; Blackburn, Amy; Vire, Bérengère; Maric, Irina; Stetler-Stevenson, Maryalice; Yuan, Constance M; Eckhaus, Michael A; Soto, Susan; Farooqui, Mohammed Z H; Taylor, Ronald P; Rader, Christoph; Wiestner, Adrian

State of the art biology, progression, and clinical management of monoclonal B-cell lymphocytosis (MBL): consensus report from the Intercepting Blood Cancers Workshop Committee

单克隆B细胞淋巴细胞增多症(MBL)的最新生物学、进展和临床管理:血液肿瘤拦截研讨会委员会共识报告

Ryan, Christine E; Ahn, Inhye E; Sekar, Aswin; Rawstron, Andrew; Almeida, Julia; Martin-Subero, Iñaki; Parry, Erin M; Alcoceba, Miguel; Calado, Dinis P; Orfao, Alberto; Langerak, Anton W; Veelken, Hendrik; Langerbeins, Petra; Stephens, Deborah M; Parikh, Sameer A; Niemann, Carsten U; Roulland, Sandrine; Stamatopoulos, Kostas; Slager, Susan L; Shanafelt, Tait; Ghia, Paolo; Okosun, Jessica; Davids, Matthew S

Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia

双重难治性和双重暴露慢性淋巴细胞白血病患者的特征和预后

Yoon, James T; Zhou, Yinglu; Mikhaleva, Mariia; Choi, Daniel S; Fernandes, Stacey M; Armand, Philippe; Bessnow, Amy C; Crombie, Jennifer L; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; LaCasce, Ann S; Merryman, Reid W; Odejide, Oreofe O; Parry, Erin M; Qualls, David A; Ryan, Christine E; Sekar, Aswin; Soumerai, Jacob D; Arnason, Jon; Tyekucheva, Svitlana; Davids, Matthew S; Brown, Jennifer R; Ahn, Inhye E

Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL

2024年淋巴瘤研究基金会研讨会关于慢性淋巴细胞白血病(CLL)或小淋巴细胞淋巴瘤(SLL)治疗选择和顺序的共识建议

Soumerai, Jacob D; Barrientos, Jacqueline; Ahn, Inhye; Coombs, Catherine; Gladstone, Douglas; Hoffman, Marc; Kittai, Adam; Jacobs, Ryan; Lipsky, Andrew; Patel, Krish; Rhodes, Joanna; Skarbnik, Alan; Thompson, Meghan; Ermann, Daniel; Reville, Patrick; Shah, Harsh; Brown, Jennifer R; Stephens, Deborah M

A giant stem-group chaetognath

巨型干群毛颚动物

Park, Tae-Yoon S; Nielsen, Morten Lunde; Parry, Luke A; Sørensen, Martin Vinther; Lee, Mirinae; Kihm, Ji-Hoon; Ahn, Inhye; Park, Changkun; de Vivo, Giacinto; Smith, M Paul; Harper, David A T; Nielsen, Arne T; Vinther, Jakob

Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL

一项评估伊布替尼联合氟达拉滨、环磷酰胺和利妥昔单抗作为慢性淋巴细胞白血病一线治疗方案的II期研究的五年随访结果

Ahn, Inhye E; Brander, Danielle M; Ren, Yue; Zhou, Yinglu; Tyekucheva, Svitlana; Walker, Heather A; Black, Robert; Montegaard, Josie; Alencar, Alvaro; Shune, Leyla; Omaira, Mohammad; Jacobson, Caron A; Armand, Philippe; Ng, Samuel Y; Crombie, Jennifer; Fisher, David C; LaCasce, Ann S; Arnason, Jon; Hochberg, Ephraim P; Takvorian, Ronald W; Abramson, Jeremy S; Brown, Jennifer R; Davids, Matthew S